Pharmacological aspects of neonatal antidepressant withdrawal.
about
The use of psychotropic medication during pregnancy: how about the newborn?Antidepressants, anxiolytics, and hypnotics in pregnancy and lactationPharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringNeonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesPharmacological treatment of unipolar depression during pregnancy and breast-feeding--a clinical overview.The management of mood disorders in pregnancy: alternatives to antidepressants.Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.Mother-infant antidepressant concentrations, maternal depression, and perinatal eventsClomipramine concentration and withdrawal symptoms in 10 neonates.When the bough breaks: rethinking treatment strategies for perinatal depression.Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors.Risk factors for poor neonatal adaptation after exposure to antidepressants in utero.Adapted Finnegan scoring list for observation of anti-depressant exposed infants.Methadone and perinatal outcomes: a prospective cohort study.
P2860
Q24625025-3A5D1B8A-8EF1-45A5-9951-8D108014FC7CQ26795384-9D3FD74A-E224-486B-8A83-374A3E01F213Q27027293-2EEE770E-4699-4746-8300-B565EB154AFCQ30249670-AC8E01B9-C550-4FC2-AFF5-EDA1B60615AEQ34018881-FD13B981-66EB-4106-A5AC-28B4A2A9CA17Q34237681-3B2CB843-EE9F-4DD7-96E4-B2042F723D01Q34250131-97961041-128B-49E3-9F55-F9B287E43FC3Q34338163-B7DAF539-8D97-46C9-852A-C9810CD39845Q34445231-4B27D56A-B3E8-4F66-9E7F-DA45A160D6BAQ35172179-E5C2752B-EBA7-48F1-9D5E-5313941768ABQ35718651-971B6A7C-5AE2-47EA-BC5F-FD6EF9A9B4C6Q38089040-B4D6DF71-43F5-4B03-816D-37F2ECFBD0D8Q38857229-0B02C656-D96E-4E7B-B73A-EC03AAF02406Q41624880-01FFFAFE-1F3D-45B7-825A-5449B71D70ADQ44056145-50F6718C-A190-4859-BC85-22AE12EE69F3Q52300330-2072AF0B-C289-490B-B034-E9097EC04350
P2860
Pharmacological aspects of neonatal antidepressant withdrawal.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological aspects of neonatal antidepressant withdrawal.
@en
Pharmacological aspects of neonatal antidepressant withdrawal.
@nl
type
label
Pharmacological aspects of neonatal antidepressant withdrawal.
@en
Pharmacological aspects of neonatal antidepressant withdrawal.
@nl
prefLabel
Pharmacological aspects of neonatal antidepressant withdrawal.
@en
Pharmacological aspects of neonatal antidepressant withdrawal.
@nl
P2093
P1476
Pharmacological aspects of neonatal antidepressant withdrawal.
@en
P2093
Frank G A Jansman
Jacobus R B J Brouwers
Jan-Pieter Smit
Peter G J Ter Horst
Richard A van Lingen
P304
P356
10.1097/OGX.0B013E3181676BE8
P577
2008-04-01T00:00:00Z